ANI Pharmaceuticals (ANIP) Earnings Date, Estimates & Call Transcripts

$65.62
+0.14 (+0.21%)
(As of 04/22/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 10
Before Market Opens
Confirmed
Actual EPS
(Feb. 29)
$0.78 Beat By $0.20
Consensus EPS
(Feb. 29)
$0.58
Skip Charts & View Estimated and Actual Earnings Data

ANIP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ANIP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ANI Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.72$0.72$0.72 
Q2 20241$0.84$0.84$0.84 
Q3 20241$1.03$1.03$1.03 
Q4 20241$1.09$1.09$1.09 
FY 20244$3.68$3.68 $3.68

ANIP Earnings Date and Information

ANI Pharmaceuticals last issued its quarterly earnings results on February 29th, 2024. The specialty pharmaceutical company reported $0.78 earnings per share for the quarter, topping analysts' consensus estimates of $0.58 by $0.20. The firm had revenue of $131.65 million for the quarter, compared to the consensus estimate of $123.02 million. ANI Pharmaceuticals has generated $0.84 earnings per share over the last year ($0.84 diluted earnings per share) and currently has a price-to-earnings ratio of 78.1. Earnings for ANI Pharmaceuticals are expected to grow by 16.62% in the coming year, from $3.55 to $4.14 per share. ANI Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Friday, May 10th, 2024. ANI Pharmaceuticals will be holding an earnings conference call on Friday, May 10th at 8:30 AM Eastern. Interested parties can register for or listen to the call. or dial in at 800-938-2239 with passcode "4555224".

ANI Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/10/2024
Confirmed)
-------  
2/29/2024Q4 2023$0.58$0.78+$0.20$1.52$123.02 million$131.65 million
11/8/2023Q3 2023$0.84$1.27+$0.43$1.65$111.92 million$131.83 million      
8/9/2023Q2 2023$0.64$1.28+$0.64$1.83$99.87 million$116.50 million      
5/8/2023Q1 2023$0.16$0.97+$0.81$1.88$82.99 million$106.79 million
3/9/2023Q4 2022$0.49$0.59+$0.10$1.46$86.76 million$94.23 million
11/9/2022Q3 2022$0.40$0.46+$0.06$1.47$78.71 million$83.82 million
8/8/2022Q2 2022($0.04)($0.05)($0.01)$0.84$71.00 million$73.86 million    
5/10/2022Q1 2022($0.05)($0.27)($0.22)$0.73$65.50 million$64.48 million      
3/15/2022Q4 2021$0.69$0.38($0.31)$2.48$58.25 million$60.93 million    
10/31/2021Q3 2021$0.70$1.01+$0.31$2.03$50.30 million$52.06 million    
8/5/2021Q2 2021$0.51$0.67+$0.16$2.15$47.80 million$48.63 million      
5/6/2021Q1 2021$0.71$1.04+$0.33$1.83$48.00 million$54.52 million    

ANI Pharmaceuticals Earnings - Frequently Asked Questions

When is ANI Pharmaceuticals's earnings date?

ANI Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Friday, May 10th, 2024. Learn more on ANIP's earnings history.

Did ANI Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, ANI Pharmaceuticals (NASDAQ:ANIP) reported $0.78 earnings per share (EPS) to beat the analysts' consensus estimate of $0.58 by $0.20. Learn more on analysts' earnings estimate vs. ANIP's actual earnings.

How much revenue does ANI Pharmaceuticals generate each year?

ANI Pharmaceuticals (NASDAQ:ANIP) has a recorded annual revenue of $486.82 million.

How much profit does ANI Pharmaceuticals generate each year?

ANI Pharmaceuticals (NASDAQ:ANIP) has a recorded net income of $18.78 million. ANIP has generated $0.84 earnings per share over the last four quarters.

What is ANI Pharmaceuticals's price-to-earnings ratio?

ANI Pharmaceuticals (NASDAQ:ANIP) has a trailing price-to-earnings ratio of 78.12 and a forward price-to-earnings ratio of 18.48.

What is ANI Pharmaceuticals's EPS forecast for next year?

ANI Pharmaceuticals's earnings are expected to grow from $3.55 per share to $4.14 per share in the next year, which is a 16.62% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:ANIP) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners